1. Home
  2. RLAY vs CBT Comparison

RLAY vs CBT Comparison

Compare RLAY & CBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Relay Therapeutics Inc.

RLAY

Relay Therapeutics Inc.

HOLD

Current Price

$18.33

Market Cap

3.8B

Sector

Health Care

ML Signal

HOLD

Logo Cabot Corporation

CBT

Cabot Corporation

HOLD

Current Price

$74.39

Market Cap

4.4B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
RLAY
CBT
Founded
2015
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Major Chemicals
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
3.8B
4.4B
IPO Year
2020
1994

Fundamental Metrics

Financial Performance
Metric
RLAY
CBT
Price
$18.33
$74.39
Analyst Decision
Strong Buy
Hold
Analyst Count
13
6
Target Price
$27.58
★ $90.33
AVG Volume (30 Days)
★ 2.5M
341.8K
Earning Date
11-05-2026
11-02-2026
Dividend Yield
N/A
★ 2.56%
EPS Growth
★ 31.78
N/A
EPS
N/A
★ 2.77
Revenue
$15,355,000.00
★ $3,713,000,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$60.51
$3.16
P/E Ratio
★ N/A
$26.57
Revenue Growth
★ 53.44
N/A
52 Week Low
$5.95
$58.33
52 Week High
$21.27
$94.53

Technical Indicators

Market Signals
Indicator
RLAY
CBT
Relative Strength Index (RSI) 51.84 36.89
Support Level $17.67 $72.92
Resistance Level $20.09 $76.81
Average True Range (ATR) 0.97 1.52
MACD 0.10 0.04
Stochastic Oscillator 65.28 28.50

Price Performance

Historical Comparison
RLAY
CBT

About RLAY Relay Therapeutics Inc.

Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process and bringing life-changing therapies to patients. The Dynamo platform of the company integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-8186, RLY-2608, RLY-4008 and others.

About CBT Cabot Corporation

Cabot Corp manufactures and sells a variety of chemicals, materials, and chemical-based products. The company organizes itself into the following operating segments based on the product type; the Reinforcement Materials segment which generates maximum revenue provides reinforcing carbon products used in tires, and industrial products such as hoses, belts, extruded profiles, and molded goods; and the Performance Chemicals segment aggregates the specialty carbons, specialty compounds, fumed metal oxides, battery materials, inkjet colorants, and aerogel product lines. Geographically, the company derives maximum revenue from its customers in Europe, the Middle East, and Africa and the rest from the Americas and Asia Pacific region.

Share on Social Networks: